Innovation Pharmaceuticals Inc (CTIX) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket
 


Innovation Pharmaceuticals Inc   (CTIX)


Innovation Pharmaceuticals Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Innovation Pharmaceuticals Inc's ROI in the first quarter of 2024?
Innovation Pharmaceuticals Inc recorded a cumulative net loss of $-3 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -93.95%.

Within the Healthcare sector 786 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 4354, from total ROI ranking in the fourth quarter of 2023 at 4371.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
Y / Y Investment Change TTM -56.12 % -53.76 % -47.29 % -41.4 % -21.48 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 2 3 4 4
Return On Investment (TTM) -93.95 % -92.21 % -97.82 % -94.65 % -100.9 %
CTIX's Overall Ranking # 4354 # 4371 # 3480 # 4724 # 0
Seq. Investment Change TTM -18.83 % -18.28 % -18.8 % -18.53 % -14.46 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3 -3 -4 -5 -6




Return On Investment CTIX's Ranking
Within: No.
Industry # 366
Sector # 787
Overall # 4354

Return On Investment Statistics
High Average Low
-92.21 %
-308.64 %
-1246.33 %
(Jun 30 2023)   (Jun 30 2014)







Financial Statements
Innovation Pharmaceuticals Inc's I. Quarter Investments $ 2 Millions CTIX's Balance sheet
Innovation Pharmaceuticals Inc's I. Quarter Income $ -1 Millions Quarterly CTIX's Income Statement
CTIX's Income by Division See CTIX's Income by Division


CTIX Annual Return On Investment (Jun 30 2023)
2023
(Jun 30 2022)
2022
(Jun 30 2021)
2021
(Jun 30 2020)
2020
(Jun 30 2019)
2019
Total Investments in Millions 2 6 8 2 -1
Y / Y Investment Growth -55.2 % -28.22 % 313.04 % - -
Net Income in Millions -3 -7 -14 -7 -9
Y / Y Net Income Growth - - - - -
Annual Return On Investment -126.92 % -126.39 % -178.74 % -353.81 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CTIX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CTIX's Competitors
Subscribers only: Roi for Innovation Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CTIX's Customers

Other Ratios
CTIX's Roa CTIX's Inventory Turnover Ratio CTIX's Growth Rates CTIX's Dividend Statistics
CTIX's Profitability Ratios CTIX's Asset Turnover Ratio CTIX's Dividend Growth
CTIX's Roe CTIX's Valuation Ratios CTIX's Financial Strength Ratios CTIX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI


Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.